Latest News and Press Releases

InStride Health names Don LeBlanc CCO and Joe Pietrzak CFO to help scale its proven pediatric anxiety and OCD care model nationwide.

FDA has cleared the new Magstim Rapid TMS system for research and clinical applications, now with FDA clearance in the U.S. for the treatment of pain.

UKCA Approves Magstim Horizon Inspire TMS for NHS & Private UK Clinics. UK Made System for Patient Treatment of MDD, OCD and Decreasing Anxiety.

FDA clears Magstim INSPIRE Transcranial Magnetic Stimulation TMS system to treat patients with Depression, OCD, Anxious Depression

Lake in the Hills, IL, May 07, 2024 (GLOBE NEWSWIRE) -- Foster Counseling and Therapy is proud to announce its specialized services for anxiety and Obsessive-Compulsive Disorder (OCD) in the Lake...

WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...

New York, June 06, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Childhood Anxiety and OCD: Can Cognitive...

MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...

MUNICH, Nov. 21, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...

CHICAGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Compass now offers Virtual Reality Care in its Adult Obsessive-Compulsive Disorder (OCD) and Complex Anxiety Programs across in-person locations and...